BMS Bets $8.4bn On Biokin’s Bispecific ADC

New Validation Of Chinese Innovation

 
• By Dexter Jie Yan
acquisition deal
BL-B01D1 adds another ADC to BMS's diverse pipeline • Source: Shutterstock

More from China

More from Focus On Asia